Emerging Technologies: Healthcare Communication Friend or Foe?
Embracing emerging technologies and innovations is not just an option but a necessity for biopharma, HCPs, and organizations looking to thrive in the digital age...
Read MoreTop Stories
Cactus Life Sciences Announces the Acquisition
FOR IMMEDIATE RELEASE Princeton, NJ, April 24, 2024 - Cactus...
Cactus Life Sciences Appoints Oliver Dennis to
Princeton, NJ, April 16, 2024 - Cactus Life Sciences, a...
Optimizing Medical Affairs with Modular Content:
Turn your organization into an “efficiency powerhouse” with...
Filter
Why Do Plain Language Clinical Trial Summaries Matter?
Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...
Beyond Words: How Voice, Graphics, and Video Are Changing the Way Researchers Reach Audiences
The growth and adoption of the internet and mobile technology have provided publishers and authors...
3 Interesting Facts about Plain Language Summaries
Did you know these 3 facts about plain language summaries?...
Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?
A majority of patients feel lay summaries for clinical trials are very important and won’t...
Digital Scientific Content: Stakeholder Perspectives
What do the different relevant stakeholder groups truly expect from pharma-generated scientific content?...
How to Incorporate and Drive Equity, Diversity, and Inclusion in Medical Communications and Publications
A roadmap on how to drive advocacy for EDI in medical communications and publications and...